Hiroaki Ozasa

Kyoto University, Kyoto University Hospital

Papers

Total Citations

H-Index

About

Dr. Hiroaki Ozasa is a thoracic surgeon whose research focuses on the intersection of immunotherapy and surgical intervention for lung cancer, particularly non-small cell lung cancer (NSCLC). His most cited work, a 2024 study on salvage surgery following immune checkpoint inhibitor (ICI) therapy, addresses a critical gap in oncologic care: the role of surgery for patients whose initially unresectable tumors become operable after ICI treatment. With six citations, this paper provides foundational insights into the characteristics and outcomes of this emerging clinical scenario, highlighting how ICIs can convert inoperable cases to surgical candidates, potentially improving long-term survival. Dr. Ozasa also contributes to the understanding of rare thoracic malignancies, as seen in his work on paratracheal middle mediastinal thymic carcinomas. His research bridges medical oncology and thoracic surgery, offering practical guidance for multidisciplinary management of advanced lung cancer. By documenting the safety and efficacy of salvage surgery post-ICI, Dr. Ozasa is shaping treatment paradigms for patients with limited options, making his work highly relevant to clinicians and researchers navigating the evolving landscape of immunotherapy and surgical oncology.